MSA’s Chief Science Officer, Kenneth Dretchen, PhD is a co-author on second paper on the detection of Aripirazole in urine

Posted on:

Clinical Trial correlates urine metabolite concentration with dose of orally administered aripiprazole (Abilify) – October 10, 02014

Dr. Dretchen, MSA CSO, is a co-author on a manuscript accepted for publication in Psychopharmacology entitled “Quantitative Levels of Aripiprazole Parent Drug and Metabolite in Urine”. The results of this study showed that there was a quantitative relationship between the doses of Aripiprazole administered orally and the level of a specific metabolite measured in the urine.

Click here to view the Aripirazole abstract from the latest article